US Medical Innovations’ CHPS handpiece

Takoma Park, Maryland – US Medical Innovations (USMI) officials announce the company’s Canady Hybrid Plasma Scalpel (CHPS) handpiece.

The CHPS is the first multifunctional electrosurgical scalpel in the world allowing a surgeon to simultaneously cut and coagulate through biological tissue at a temperature of less than 98°F, significantly reducing intraoperative blood loss and operative time, improving wound healing, minimizing the length of stay for the patient, and reducing the risk of hospital acquired infections.

The CHPS incorporates four separate operating modes: hybrid plasma, argon plasma coagulation, conventional monopolar cut, and coagulation, which can be used in a range of subspecialties, such as cardiovascular surgery, endoscopy, ENT, general surgery, gynecology, neurosurgery, orthopaedic, plastics, surgical oncology, thoracic surgery, and dermatology.

“Since 2010, my team and I have worked to fill the opportunity gap in electrosurgery to make new plasma technologies available as viable options to benefit both medical professionals and their patients,” said Jerome Canady, MD.

Canady Biotechnology LLC, USMI’s new manufacturing affiliate, officially commenced operations at its newly constructed Canady Innovation Center (CIC) in Takoma Park, Maryland. The CIC, which falls under the umbrella of parent company U.S. Patent Innovations LLC (USPI), houses a multidisciplinary team of engineers, healthcare professionals, clinicians, physicians and scientists from around the world, for the coordination of rapid research, design, production, and marketing of plasma medical devices. 

USMI’s recent repatriation of its manufacturing from Latin America to the U.S. helps promote economic development in Montgomery County, Maryland, creating 25 highly skilled manufacturing-related jobs stateside. USMI projects it will employ up to 100 highly skilled medical and technology professionals within the next year as the company continues expanding to meet sales projections. To date, more than 50 medical facilities have purchased and currently use USMI products.

The CIC will house a family of affiliates within one facility. These affiliates include Canady Biotechnology, LLC (Manufacturing); Canady Robotics, LLC (Robotic Products); Plasma Medicine Life Sciences, LLC (Design & Development); and the Jerome Canady Research Institute for Advanced Biological and Technological Sciences, Benefit LLC (Translational and Molecular Research). 

Source: US Medical Innovations